Speculative Investment. Transgenomic acknowledges that the investment in Geron represented by the Shares is highly speculative in nature and is subject to a high degree of risk of loss in whole or in part; the amount of such investment is within Transgenomic's risk capital means and is not so great in relation to Transgenomic's total financial resources as would jeopardize the personal financial needs of Transgenomic in the event such investment were lost in whole or in part.
Appears in 12 contracts
Samples: Stock Purchase Agreement (Transgenomic Inc), Common Stock Purchase Agreement (Geron Corporation), Common Stock Purchase Agreement (Geron Corporation)
